Cargando…

Prognostic value of preoperative circulating tumor cells for hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score analysis

PURPOSE: The role of circulating tumor cells (CTCs) in hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) is not fully understood. METHODS: In this retrospective analysis, we included 316 HCC patients who underwent hepatectomy and preoperative CTC detection. We selected 41 pairs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jing-jing, Li, Ya-ni, Shu, Chang, Yang, Hui-yuan, Huang, Zhao, Tao, Ran, Chen, Yue-yue, Chen, Xiao-ping, Xiao, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374672/ https://www.ncbi.nlm.nih.gov/pubmed/37160624 http://dx.doi.org/10.1007/s00432-023-04834-8

Ejemplares similares

Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: A propensity score analysis
por: Zhang, Yong-Fa, et al.
Publicado: (2016)

Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides
por: Khan, Abdul Rehman, et al.
Publicado: (2021)

Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
por: Lv, Wei-Fu, et al.
Publicado: (2018)

Tolerability and efficacy of gamma knife radiosurgery on hepatocellular carcinoma with portal vein tumor thrombosis
por: Lu, Xiao-Jie, et al.
Publicado: (2015)

Imaging findings of hepatocellular carcinoma with portal vein tumor thrombosis secondary to hepatic portal vein collateral circulation: a cross-sectional study
por: Shi, Bo, et al.
Publicado: (2023)

Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
por: Nakazawa, Takahide, et al.
Publicado: (2014)

Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Zane, Kylie E., et al.
Publicado: (2021)

Liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis
por: Kim, Sang Jin, et al.
Publicado: (2021)

Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma
por: Tortora, Raffaella, et al.
Publicado: (2023)

The Impact of Portal Vein Thrombosis on the Prognosis of Patients With Cirrhosis: A Retrospective Propensity-Score Matched Study
por: Chen, Zhiji, et al.
Publicado: (2021)

Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis
por: Liu, Bao-Jiang, et al.
Publicado: (2021)

Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis
por: Cho, Young Youn, et al.
Publicado: (2016)

The prognosis of bulky hepatocellular carcinoma with nonmajor branch portal vein tumor thrombosis
por: Jang, Tyng-Yuan, et al.
Publicado: (2019)

The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype
por: Yu, Jing-Jing, et al.
Publicado: (2021)

Postoperative adjuvant chemo (embolization) therapy for hepatocellular carcinoma with portal vein tumor thrombosis
por: Zhang, Ya-Fei, et al.
Publicado: (2018)

Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis
por: Shaohua, Li, et al.
Publicado: (2015)

Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching study
por: Su, Ke, et al.
Publicado: (2022)

Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis
por: Shui, Yongjie, et al.
Publicado: (2018)

Case Report: Combining liver partition and portal vein ligation after thrombectomy for tumor isolation (CLAPT) to treat advanced hepatocellular carcinoma with portal vein tumor thrombosis
por: Jin, Zongrui, et al.
Publicado: (2022)

Effectiveness of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Portal Vein and/or Inferior Vena Cava Tumor Thrombosis
por: Xi, Mian, et al.
Publicado: (2013)

Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis
por: Wang, Kang, et al.
Publicado: (2016)

Preoperative platelet count predicts posttransplant portal vein complications in orthotopic liver transplantation: a propensity score analysis
por: Li, Qingshan, et al.
Publicado: (2021)

Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Kim, Jina, et al.
Publicado: (2023)

Practical Effect of Sorafenib Monotherapy on Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis
por: Jeong, Soung Won, et al.
Publicado: (2013)

Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers
por: Cerrito, Lucia, et al.
Publicado: (2019)

Comment on experience with LDLT in patients with hepatocellular carcinoma and portal vein tumor thrombosis postdownstaging
por: Akbulut, Sami, et al.
Publicado: (2020)

Nomogram for Individualized Prediction of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis on Conservative Treatment
por: Liu, Yao, et al.
Publicado: (2020)

Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysis
por: Zhang, Zi-Han, et al.
Publicado: (2023)

Lenvatinib with or without stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective study
por: Ji, Xiaoquan, et al.
Publicado: (2023)

Preoperative prediction of hepatocellular carcinoma with portal vein tumor thrombus based on conventional data
por: Zhu, Pengpeng, et al.
Publicado: (2017)

Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score‐matched survival analysis
por: Gao, Yang, et al.
Publicado: (2019)

Prognostic Index for Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Treated with Radiation Therapy
por: Yu, Jeong Il, et al.
Publicado: (2011)

Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
por: Kim, Ji-Yoon, et al.
Publicado: (2013)

Three-dimensional conformal radiotherapy for portal vein tumor thrombosis alone in advanced hepatocellular carcinoma
por: Lee, Ju Hye, et al.
Publicado: (2014)

Multicenter Validation Study of a Prognostic Index for Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2014)

Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Kim, Jina, et al.
Publicado: (2022)

Hypofractionated Radiotherapy for Palliation of Main Portal Vein Tumor Thrombosis
por: Fang, Fang, et al.
Publicado: (2022)

Comparison of intra-arterial chemoembolization with and without radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a meta-analysis
por: Zhao, Qianqian, et al.
Publicado: (2016)

Radiomics-based nomogram as predictive model for prognosis of hepatocellular carcinoma with portal vein tumor thrombosis receiving radiotherapy
por: Huang, Yu-Ming, et al.
Publicado: (2022)

Adjuvant apatinib treatment after resection of hepatocellular carcinoma with portal vein tumor thrombosis: a phase II trial
por: Sun, Hui-Chuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_one1a65t4458j8lmthb0oqbbft